Chargement en cours...
肺癌免疫检查点抑制剂的联合治疗研究进展
Immune checkpoint inhibitors (ICIs) therapy is the most commonly used immunotherapy regimen at present. It has been approved for clinical treatment of melanoma, kidney cancer, head and neck cancer, bladder cancer and other tumors. It has made a breakthrough in the treatment of lung cancer and become...
Enregistré dans:
| Publié dans: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
中国肺癌杂志编辑部
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049794/ https://ncbi.nlm.nih.gov/pubmed/32093454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2020.02.05 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|